National and subnational burden of mental disorders in China, 1990–2023: a systematic analysis of the Global Burden of Disease Study 2023

作者：Yanlong Li, Zhu Xq, Li-Li Shang, Bin Zou, Li Zhang, Peipei Xu, Lijun Wang, Maigeng Zhou, Damian Santomauro, Peng Yin, Gang Wang · 发表于：The Lancet Regional Health - Western Pacific · 年份：2026 · DOI：10.1016/j.lanwpc.2026.101936 · 被引用次数：1 · 研究领域：Mental Health Treatment and Access、COVID-19 and Mental Health、Suicide and Self-Harm Studies

Background: Mental disorders represent a growing public health priority in China. Existing studies have largely relied on superseded data iterations and focused on specific population subsets or disease categories, leaving a gap in understanding the full epidemiological landscape of mental health across the country. This study provides the most up-to-date and comprehensive assessment of the burden of mental disorders in China and its provinces, utilizing the latest estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023. Methods: Following the GBD 2023 methodology, we systematically analyzed epidemiological and demographic data to assess the prevalence, disability-adjusted life year (DALY), age-standardized prevalence rate (ASPR) and age-standardized DALY rate (ASDR) for mental disorders and ten subtypes in China and its 33 provincial-level administrative units from 1990 to 2023. Findings: In 2023, the estimated ASPR of mental disorders in China was 12,706 (95% uncertainty interval: 11,438, 14,573) per 100,000 population, reflecting a 14.6% (3.5, 30.7) increase since 1990. The ASDR reached 1718 (1272, 2307) per 100,000, rising by 18.4% (5.3, 36.9) over the past three decades. Depressive and anxiety disorders remained the dominant contributors, accounting for 35.6% and 26.3% of overall DALYs attributable to mental disorders, respectively. Furthermore, eating disorders exhibited the largest growth in ASPR (63.4% [58.2, 68.2]). Substantial subna...